Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Regulatory News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.15
Bid: 3.10
Ask: 3.20
Change: -0.05 (-1.56%)
Spread: 0.10 (3.226%)
Open: 3.20
High: 3.20
Low: 3.15
Prev. Close: 3.20
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

14 Jun 2007 07:01

Fabian Romania Property Fund Ltd14 June 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or the "Fund") Fabian Romania announces the acquisition of an €8.0 million office developmentscheme in Bucharest Fabian Romania has signed a turn-key agreement with Hil Construct to purchaseits sixth office project in central Bucharest for a prospective purchase yieldof 8.9 per cent.. Completion is conditional on the attainment of the finalbuilding permit which is currently expected at the end of August 2007. The Romana office building will be built for the Fund on a centrally locatedsite on Dacia Boulevard. The building will be built to Class A specificationswith a gross area of approximately 3,000 square metres ("sqm"). The projectmanagement will be undertaken by Globus, an experienced local developer inRomania. Construction is due to commence in the fourth quarter 2007 withcompletion anticipated in the third quarter of 2009. Total construction costsare estimated to be in the order of €8.0 million. Upon completion, the building will provide a net lettable office area of around2,480 sqm over 7 floors, together with 40 car parking spaces. The building is ina prominent position with views over Plaza Romana and is likely to attractinternational tenants seeking Class A office space. Vacancy rates for Class Aoffice space in in Bucharest are less than 3 per cent.. The Fund, advised by itsinvestment manager Fabian Capital Limited ("Fabian Capital"), will assume theletting responsibility for the building. The estimated rental value of thebuilding upon completion is €715,000 per annum giving a prospective purchaseyield of 8.9 per cent.. Upon completion the Fund will pay the purchase price of €7.6 million to Hil in 3instalments; a first instalment of €2.0 million will be made for the company toacquire ownership of the land; a second instalment for construction costs ofapproximately €3.0 million; and a final payment upon practical completion of€2.6 million in the form of a bank guarantee. Including non developer relatedcosts, the total purchase price is forecast to be €8.0 million. The Fund'sequity requirement is expected to be €2 million with debt finance to fund thebalance. Dacia Boulevard is in the heart of Bucharest running between Calle Victoria andRomana Square. It is some 5 minutes by car from the Intercontinental Hotel. Thisarea is a popular office location. A number of international companies havetheir headquarters nearby. Commenting on the transaction, Mark Owen, Property Director of Fabian Capital,said: "We are pleased the Fund has signed another high quality office purchase shortlyafter the announcement of its intention to purchase the Evocenter. This newdevelopment is located in one of the most central positions you could hope toachieve in Bucharest and we are confident the Fund will achieve pre lets priorto completion. The building is flexible to provide sub 1,000 sqm floor plates ofwhich there is an under supply in the market whilst still otherwise providingClass A technical specifications. This investment will make it the third in thecentral core area of Bucharest for the Funds' expanding Portfolio." The lead advisers on the transaction were DTZ (property agent), WSP (technicaladvisers) and Tuca (legal adviser). For Comments:Fabian Romania:Mark Holdsworth +44 20 7499 9988 Nominated Adviser:Deloitte & Touche LLPJames Lewis +44 20 7936 3000 Broker:Shore Capital Stockbrokers LimitedDru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jul 20204:36 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSTrading update
4th Jun 202012:57 pmRNSHolding(s) in Company
29th May 20205:00 pmRNSTotal Voting Rights
21st May 20206:24 pmRNSHolding(s) in Company
21st May 20202:52 pmRNSHolding(s) in Company
15th May 20204:49 pmRNSHolding(s) in Company
15th May 202010:47 amRNSResult of General Meeting & Total Voting Rights
15th May 20208:30 amRNSHolding(s) in Company
28th Apr 20207:00 amRNSPlacing to raise £3m, trading update, notice of GM
17th Apr 20204:41 pmRNSSecond Price Monitoring Extn
17th Apr 20204:35 pmRNSPrice Monitoring Extension
16th Apr 20204:41 pmRNSSecond Price Monitoring Extn
16th Apr 20204:36 pmRNSPrice Monitoring Extension
16th Apr 20203:51 pmRNSResearch Alliance with Queen’s University Belfast
16th Apr 20202:06 pmRNSSecond Price Monitoring Extn
16th Apr 20202:01 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSTrading update
19th Mar 20207:00 amRNSBelfast investor presentation
17th Mar 20207:00 amRNSDirector/PDMR Shareholding
17th Feb 20207:00 amRNSBelfast investor presentation
3rd Feb 202012:01 pmRNSDirector/PDMR Shareholding
30th Jan 20204:40 pmRNSSecond Price Monitoring Extn
30th Jan 20204:35 pmRNSPrice Monitoring Extension
29th Jan 20207:00 amRNSTrading update
10th Jan 202011:47 amRNSDirector/PDMR Shareholding
3rd Dec 20199:26 amRNSDirector/PDMR Shareholding
2nd Dec 20197:00 amRNSHalf-year Report
26th Nov 201911:13 amRNSNotice of Results
22nd Oct 20197:00 amRNSHalf year trading update
26th Sep 20199:54 amRNSDirector/PDMR Shareholding
20th Sep 20192:14 pmRNSResult of AGM
21st Aug 20197:00 amRNSPosting of Annual Report & Notice of AGM
3rd Jul 20194:09 pmRNSDirector/PDMR Shareholding
2nd Jul 20197:00 amRNSFinal Results
29th Apr 20192:46 pmRNSDirector/PDMR Shareholding
25th Apr 20194:40 pmRNSSecond Price Monitoring Extn
25th Apr 20194:35 pmRNSPrice Monitoring Extension
18th Apr 20197:00 amRNSInvestor presentation
17th Apr 20197:00 amRNSTrading Update
25th Feb 20197:00 amRNSTrading Statement
21st Dec 20187:00 amRNSGrant of Options
17th Dec 20187:00 amRNSLaunch of Rational Affinity Maturation Platform
3rd Dec 20181:39 pmRNSDirector/PDMR Shareholding
26th Nov 20187:00 amRNSHalf-year Report
19th Nov 20187:00 amRNSNotice of Results
25th Sep 20182:23 pmRNSDirector/PDMR Shareholding
24th Sep 20184:13 pmRNSDirector/PDMR Shareholding
21st Sep 201811:24 amRNSResult of AGM
28th Aug 20187:00 amRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.